Warfarin 5 mg tablet
Public data on warfarin from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
NADAC per unit, monthly
WARFARIN SODIUM 5 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.07510 |
| 2014-02 | 0.08070 |
| 2014-05 | 0.08060 |
| 2014-08 | 0.09548 |
| 2014-11 | 0.18365 |
| 2015-02 | 0.18992 |
| 2015-05 | 0.19745 |
| 2015-08 | 0.19912 |
| 2015-11 | 0.16712 |
| 2016-02 | 0.17146 |
| 2016-05 | 0.17113 |
| 2016-08 | 0.14700 |
| 2016-11 | 0.14570 |
| 2017-02 | 0.14077 |
| 2017-05 | 0.12798 |
| 2017-08 | 0.12568 |
| 2017-11 | 0.12286 |
| 2018-02 | 0.12490 |
| 2018-05 | 0.11703 |
| 2018-08 | 0.10838 |
| 2018-11 | 0.10926 |
| 2019-02 | 0.10871 |
| 2019-05 | 0.10336 |
| 2019-08 | 0.10675 |
| 2019-11 | 0.09974 |
| 2020-02 | 0.10433 |
| 2020-05 | 0.09655 |
| 2020-08 | 0.09950 |
| 2020-11 | 0.11013 |
| 2021-02 | 0.10349 |
| 2021-05 | 0.11684 |
| 2021-08 | 0.11018 |
| 2021-11 | 0.10797 |
| 2022-02 | 0.10559 |
| 2022-05 | 0.10009 |
| 2022-08 | 0.11058 |
| 2022-11 | 0.10083 |
| 2023-02 | 0.10544 |
| 2023-05 | 0.09555 |
| 2023-08 | 0.09864 |
| 2023-11 | 0.09211 |
| 2024-02 | 0.09884 |
| 2024-05 | 0.09296 |
| 2024-08 | 0.09076 |
| 2024-11 | 0.09193 |
| 2025-02 | 0.09538 |
| 2025-05 | 0.09499 |
| 2025-08 | 0.09874 |
| 2025-11 | 0.09522 |
| 2026-02 | 0.08628 |
| 2026-05 | 0.08500 |
| 2026-08 | 0.08877 |
| 2026-11 | 0.08916 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning warfarin
openFDA enforcement records, by year reported.
| 2024 | 2 |
| 2023 | 1 |
| 2015 | 1 |
| 2014 | 4 |
| 2013 | 1 |
9 records since 2012. A record is one product or lot, not one recall event. Combination products that contain warfarin are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention warfarin
11 GxRadar articles cite or discuss this drug.
What pharmacies paid for warfarin and clopidogrel, 2013 to 2026
Federal NADAC data show generic warfarin jumped in 2014 and never returned to its 2013 price, while clopidogrel, generic since 2012, lost more than half its price in two bursts.
Narrow therapeutic index drugs and the tighter test for their generics
Warfarin, levothyroxine, phenytoin and a few other drugs face a stricter generic test scaled to the brand's own variability. How it works, which drugs it covers and where state law adds rules.
The generics that cost pharmacies more than they did in 2014
Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.
Scored tablets and what the label says about them
Since 2013, FDA has reserved the phrase "functional scoring" for tablets tested to split evenly. Where that wording appears on a prescription label, what sits behind it, and how often it shows up in FDA's data.
The pharmacist's role in generic substitution
What a pharmacist checks before swapping in a generic: the Orange Book code, the prescriber's instructions, state rules for narrow therapeutic index drugs, and the counseling duty set by OBRA '90.
Reference listed drug, reference standard and basis of submission, explained
Every generic copies one approved product and is tested against another, and they are often not the same pill. How FDA defines the RLD and the reference standard, and what the Orange Book shows for common generics.